STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
293
13F, latest reported quarter
What the filings say about INGR
Insiders, 180 days
-$170.0K net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-10-14
Planned sales (Form 144), 90 days
$170.0K
1 notice
Ingredion insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Ingredion Inc insiders sold a net $170.0K of stock across 111 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Dec 5, 2025.
The trade is 0.0% of the 13,236 shares held after it.
1 other insider sold within 30 days.
293 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Uribe Jorge A. sold about $83 of INGR on Mar 31, 2026; 1 other insider sold within 30 days and 293 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Mar 1, 2024.
The trade is 5.3% of the 7,110 shares held after it.
3 other insiders sold within 30 days.
293 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP Corp. Controller, Finance Gable Davida Marie sold about $42.2K of INGR on Mar 18, 2026; 3 other insiders sold within 30 days and 293 funds added in the latest 13F quarter.
14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Feb 11, 2026.
The trade is 30.2% of the 33,010 shares held after it.
2 other insiders sold within 30 days.
293 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Zallie James P. sold about $1.2M of INGR on Feb 18, 2026; 2 other insiders sold within 30 days and 293 funds added in the latest 13F quarter.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Feb 11, 2026.
The trade is 3.7% of the 30,514 shares held after it.
2 other insiders sold within 30 days.
293 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Chief Comm & Sust Officer Fernandes Larry sold about $131.1K of INGR on Feb 18, 2026; 2 other insiders sold within 30 days and 293 funds added in the latest 13F quarter.
111 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
INGR planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Fischer David B
Filed 2026-08-05
$170.0K
INGR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
First Trust Consumer Staples AlphaDEX Fund
$9.8M position · as of 2026-07-31
4.3%
1789 GROWTH AND INCOME FUND
$1.4M position · as of 2026-07-31
4.2%
Monarch Dividend Plus Index ETF
$1.9M position · as of 2026-05-31
3.2%
Cambiar Small Cap Fund
$1.7M position · as of 2026-07-31
2.5%
Invenomic Fund
$20.4M position · as of 2026-07-31
2.4%
Applied Finance Dividend Fund
$804.4K position · as of 2026-07-31
2.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · James Zallie
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$12.9M
$5.3M
$2.6M
+60%
+34%
2024
$11.9M
$26.6M
$2.5M
+95%
+25%
2023
$11.1M
$19.4M
$2.3M
+51%
+21%
2022
$9.5M
$14.5M
$2.4M
+32%
+26%
2021
$10.3M
$14.2M
$2.7M
+26%
+16%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $170.0K sold by insiders over 180 days, 293 funds added last quarter, $170.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$7.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM INGR
FY Dec 2025
$7.2B
FY Dec 2024
$7.4B
FY Dec 2023
$8.2B
FY Dec 2022
$7.9B
FY Dec 2021
$6.9B
Jun 2026
$1.9B
Mar 2026
$1.8B
Dec 2025
$1.8B
Sep 2025
$1.8B
Jun 2025
$1.8B
Mar 2025
$1.8B
Dec 2024
$1.8B
Sep 2024
$1.9B
At each fiscal year end
Single quarter
Net margin, TTM
+8.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM INGR
FY Dec 2025
+10.1%
FY Dec 2024
+8.7%
FY Dec 2023
+7.9%
FY Dec 2022
+6.2%
FY Dec 2021
+1.7%
Jun 2026
+6.2%
Mar 2026
+7.9%
Dec 2025
+9.4%
Sep 2025
+9.4%
Jun 2025
+10.7%
Mar 2025
+10.9%
Dec 2024
+5.3%
Sep 2024
+10.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$355.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM INGR
FY Dec 2025
$511.0M
FY Dec 2024
$1.1B
FY Dec 2023
$743.0M
FY Dec 2022
-$148.0M
FY Dec 2021
$92.0M
Jun 2026
-$10.0M
Mar 2026
-$77.0M
Dec 2025
$270.0M
Sep 2025
$172.0M
Jun 2025
$84.0M
Mar 2025
-$15.0M
Dec 2024
$311.0M
Sep 2024
$429.0M
At each fiscal year end
Single quarter
Debt to equity
0.39x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity INGR
FY Dec 2025
0.42x
FY Dec 2024
0.48x
FY Dec 2023
0.62x
FY Dec 2022
0.79x
FY Dec 2021
0.66x
Jun 2026
0.39x
Mar 2026
0.42x
Dec 2025
0.42x
Sep 2025
0.42x
Jun 2025
0.43x
Mar 2025
0.45x
Dec 2024
0.48x
Sep 2024
0.47x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.45x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt INGR
FY Dec 2025
0.53x
FY Dec 2024
0.78x
FY Dec 2023
0.48x
FY Dec 2022
0.06x
FY Dec 2021
0.19x
Jun 2026
0.45x
Mar 2026
0.49x
Dec 2025
0.53x
Sep 2025
0.54x
Jun 2025
0.66x
Mar 2025
0.73x
Dec 2024
0.78x
Sep 2024
0.77x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+13.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity INGR
FY Dec 2025
+18.0%
FY Dec 2024
+17.6%
FY Dec 2023
+19.2%
FY Dec 2022
+15.8%
FY Dec 2021
+3.9%
Jun 2026
+13.6%
Mar 2026
+16.1%
Dec 2025
+18.0%
Sep 2025
+16.1%
Jun 2025
+17.1%
Mar 2025
+16.3%
Dec 2024
+17.6%
Sep 2024
+18.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets INGR
FY Dec 2025
+9.5%
FY Dec 2024
+8.6%
FY Dec 2023
+8.5%
FY Dec 2022
+6.8%
FY Dec 2021
+1.7%
Jun 2026
+7.5%
Mar 2026
+8.8%
Dec 2025
+9.5%
Sep 2025
+8.6%
Jun 2025
+9.0%
Mar 2025
+8.5%
Dec 2024
+8.6%
Sep 2024
+9.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.0%
operating income after a 26.7% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital INGR
FY Dec 2025
+15.9%
FY Dec 2024
+12.9%
FY Dec 2023
+14.2%
FY Dec 2022
+10.8%
FY Dec 2021
+3.4%
Jun 2026
+12.0%
Mar 2026
+13.9%
Dec 2025
+15.9%
Sep 2025
+13.9%
Jun 2025
+13.9%
Mar 2025
+13.0%
Dec 2024
+12.9%
Sep 2024
+13.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed INGR
FY Dec 2025
+15.9%
FY Dec 2024
+14.7%
FY Dec 2023
+16.6%
FY Dec 2022
+13.6%
FY Dec 2021
+5.7%
Jun 2026
+12.9%
Mar 2026
+14.6%
Dec 2025
+15.9%
Sep 2025
+14.9%
Jun 2025
+15.6%
Mar 2025
+15.4%
Dec 2024
+14.7%
Sep 2024
+15.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.44x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing INGR
FY Dec 2025
9.88x
FY Dec 2024
14.17x
FY Dec 2023
11.31x
FY Dec 2022
13.34x
FY Dec 2021
56.85x
Jun 2026
10.33x
Mar 2026
10.85x
Dec 2025
9.88x
Sep 2025
12.17x
Jun 2025
13.23x
Mar 2025
14.26x
Dec 2024
14.17x
Sep 2024
13.41x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$6.9B
market value at close 2026-10-23 on 2026-08-05 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value INGR
FY Dec 2025
$7.8B
FY Dec 2024
$9.8B
FY Dec 2023
$8.9B
FY Dec 2022
$8.7B
FY Dec 2021
$8.1B
Jun 2026
$6.8B
Mar 2026
$8.0B
Dec 2025
$7.8B
Sep 2025
$8.7B
Jun 2025
$9.6B
Mar 2025
$9.6B
Dec 2024
$9.8B
Sep 2024
$9.9B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield INGR
FY Dec 2025
+7.3%
FY Dec 2024
+12.7%
FY Dec 2023
+10.5%
FY Dec 2022
-2.3%
FY Dec 2021
+1.4%
Jun 2026
+5.9%
Mar 2026
+6.3%
Dec 2025
+7.3%
Sep 2025
+7.0%
Jun 2025
+9.3%
Mar 2025
+11.3%
Dec 2024
+12.7%
Sep 2024
+13.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -11%, PEG needs growth
PEG, trailing INGR
FY Dec 2025
0.66x
FY Dec 2024
12.36x
FY Dec 2023
0.37x
FY Dec 2022
0.04x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
1.14x
Dec 2025
0.66x
Sep 2025
n/a
Jun 2025
2.75x
Mar 2025
n/a
Dec 2024
12.36x
Sep 2024
1.38x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
INGR ranks highest on profitability (68th percentile) and financial health (68th), and lowest on insider conviction (22nd), among Food & Beverage peers.
Profitability
68
Inputs
Return on equity+13.6% · 71 pct, sector of 66
Return on assets+7.5% · 71 pct, sector of 77
Return on invested capital+12.0% · 55 pct, sector of 32
Return on capital employed+12.9% · 75 pct, sector of 62
Financial health
68
Inputs
Debt to equity0.39x · 51 pct, sector of 66
Cash flow to debt0.45x · 86 pct, sector of 59
Growth
31
Inputs
Revenue growth, YoY-2.8% · 31 pct, sector of 89
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
22
Inputs
Net Form 4 buying (codes P and S), 180d-$170K · 44 pct, sector of 56
Insider buyers, 180d0 · 0 pct, sector of 56
Institutional and government
49
Inputs
Funds adding, latest quarter293 · 69 pct, sector of 79
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$200K · 30 pct, universe of 1,063
Risk and compliance
39
Inputs
Short interest, % of float+7.7% · 34 pct, sector of 100
Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 58
EPA cases per $1B revenue, 5y0.14 per $1B · 9 pct, sector of 58
New text in Risk Factors, latest 10-K+27.6% · 14 pct, sector of 66
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
INGR filings, in plain words
Are Ingredion insiders buying or selling INGR?
In the 180 days to 2026-10-27, Ingredion insiders were net sellers, a net $170.0K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded INGR?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Lisa McClain dated 2025-10-14.
Are there planned insider sales of INGR?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $170.0K of stock; the latest, by Fischer David B, was filed 2026-08-05.
Read the full summary
In the 180 days to 2026-10-27, Ingredion insiders were net sellers of INGR, a net $170.0K across purchases and sales reported on Form 4 by 1 seller. Members of Congress have disclosed trades in INGR, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-10-14. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $170.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.